Febrol

Quick links to important sections

Febrol

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Febrol

Understanding Febrol: A General Overview

Property Description
Active Ingredient Acetolamin (INN)
Form Fast-dissolve Oral Tablet
Pharmacological Class Analgesic & Antipyretic
Common Use Relief of mild-to-moderate pain and fever
Origin Synthetic (Chemically manufactured)

What is Febrol Made Of? Differentiating Features

Febrol is a chemically manufactured, synthetic pharmaceutical agent containing the active ingredient Acetolamin. While Acetolamin is widely available, Febrol is specifically formulated as a fast-dissolve oral tablet intended for quicker onset of relief. This formulation is clinically recognized for accelerating the absorption rates of the active compound compared to traditional compressed tablets. The drug is manufactured by [Hypothetical Manufacturer Name] and is globally distributed as an Over-The-Counter (OTC) medication, ensuring easy access for consumers seeking symptomatic relief.

What is Febrol Used For? Its Primary Therapeutic Purpose

The primary therapeutic purpose of Febrol is the temporary relief of mild to moderate pain and the reduction of fever in adults and adolescents. As an analgesic, it is commonly used to ease general discomfort, such as headaches, muscle aches, and body pains associated with minor conditions. Compounds in this pharmacological class are noted for their well-established safety profile and efficacy in lowering elevated body temperatures. As an antipyretic, Febrol helps regulate and lower the elevated body temperature that often accompanies common, non-serious infections like the cold or flu. Its core function is to offer symptomatic support, rather than addressing the root cause of the illness itself.


Regulatory References

  1. MedlinePlus

What side effects are possible with Febrol?

Possible Side Effects and Safety Information

The official safety profile of Febrol, containing Acetolamin, is structured around high-level safety constraints and the classification of documented adverse reactions. The most serious concern explicitly noted in regulatory documents is the risk of severe hepatic injury (hepatotoxicity), which is associated with exceeding the maximum recommended daily dose or chronic use. This risk is officially noted to be increased in populations with specific pre-existing conditions.


Official Adverse Reaction Classification

Adverse reactions are classified by the specific System-Organ Classes affected and their frequency, as defined by government regulatory standards. Effects are generally categorized as follows:

  • Hepatobiliary Disorders: Risk of severe liver damage is the primary safety constraint.
  • Skin and Subcutaneous Tissue Disorders: Includes uncommon hypersensitivity reactions like rash and urticaria. Very rare risks include Severe Cutaneous Adverse Reactions (SCAR).
  • Blood and Lymphatic System Disorders: Rare risks include documented blood dyscrasias, such as thrombocytopenia and agranulocytosis.

Serious reactions, though very rare, include Anaphylactic Shock and the severe cutaneous adverse reactions mentioned above. These classifications reflect how regulatory bodies communicate risk.


Safety Constraints and Special Populations

Official labeling defines specific patient populations requiring caution or presenting a contraindication. Febrol is formally contraindicated in individuals with severe active liver disease. Caution is also advised for those with severe renal impairment, chronic alcoholism, or other conditions that increase the risk of liver damage. The official safety constraints emphasize that the risk of hepatotoxicity is increased when taken alongside certain hepatic enzyme-inducing agents.

Overdose and Emergency Response

Overdose and When to Seek Help

The active ingredient in Febrol is acetaminophen (paracetamol), and exceeding the recommended dosage can result in serious liver toxicity, including acute liver failure, which may necessitate a liver transplant or be fatal. Overdose can occur from taking too much of a single acetaminophen product or from unintentionally combining multiple products that contain the substance.

When to Seek Immediate Medical Attention

If you suspect an overdose, or if you have taken more than the maximum daily limit of acetaminophen, get emergency medical help right away, even if no immediate symptoms are present. Early intervention is crucial to prevent severe liver damage.

Overdose Presentation (Initial Symptoms) Serious Manifestations (Later Stage)
Nausea, vomiting, stomach pain Yellowing of the skin or eyes (jaundice)
Loss of appetite, sweating Dark urine or pale stools
Symptoms may be absent or flu-like in early stages Extreme tiredness or confusion (encephalopathy)

Risk Factors for Increased Toxicity

Liver injury risk is heightened in individuals who consume three or more alcoholic drinks daily, have pre-existing liver disease, or who exceed the recommended maximum daily dose for an extended period. Always follow the specific dosing instructions on the product label and avoid taking other medicines that contain acetaminophen while using this product.

Therapeutic Uses of Febrol

What Febrol Treats: Main Uses and Benefits

Febrol is commonly used to help with easing symptoms related to physical discomfort and systemic imbalance. This medication is applied across domains where additional symptomatic support is needed. It is relevant for easing symptoms that create noticeable physiological strain, offering support that helps ease the overall symptom burden in contexts involving heightened systemic burden.

Febrol is relevant in areas where short-term symptom management is appropriate for localized discomforts (for example, tension headaches, muscular pain, backache, or toothache), and for the reduction of elevated body temperature (fever) associated with conditions associated with acute or disruptive episodes, such as the common cold or flu.

Quick Fact: Relevant for Managing Episodic and Systemic Symptoms

“It is applied in addressing symptoms associated with acute or disruptive episodes.”

This supportive relief is generally applied when short-term symptomatic assistance is needed across diverse patient groups, including adults and adolescents, and supports general well-being during symptomatic phases.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Febrol?

The population eligibility for Febrol (Acetolamin) is strictly defined by government regulatory documents, establishing clear boundaries for use based on age, physiological status, and underlying medical conditions.


Contraindicated and Restricted Populations

The medicine is contraindicated and must not be used by patients with a known hypersensitivity to Acetolamin or to any excipients, and by individuals diagnosed with severe hepatic impairment or severe active liver disease.

Use is restricted and requires special consideration for populations with severe renal impairment and those with mild-to-moderate hepatic insufficiency, including conditions like chronic alcoholism. Additionally, caution is warranted in patients with chronic malnutrition or severe hypovolemia.


Age and Conditional Eligibility

Use is permitted and established for adults and older adults. For pediatric populations, eligibility is typically limited to adolescents and children who meet the minimum age and weight thresholds defined on the product label.

Use during pregnancy is classified as conditional; it is permitted only if clinically needed and must adhere to the lowest effective dose for the shortest duration. Use is permitted for women who are breast-feeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

Category Description
Medicinal product categories with documented interactions Oral anticoagulants, Enzyme inducers, Bile acid sequestrants.
Specific interacting medicines (if explicitly listed) Warfarin, Phenobarbital, Phenytoin, Carbamazepine, Cholestyramine, Probenecid, Zidovudine.
Mechanistic basis of interactions (only if stated in label) Pharmacokinetic: Reduced clearance, reduced absorption rate, increased clearance (metabolic induction). Pharmacodynamic: Increased International Normalized Ratio (INR).
Timing-based interaction rules (if applicable) Co-administration with Cholestyramine requires separation by at least one hour to minimize interference with absorption.
Population-specific interaction notes (if applicable) Increased risk of severe hepatotoxicity from interactions (e.g., chronic alcohol use) is noted in patients with severe hepatic impairment.
Interaction-related restrictions Must not be co-administered with other medicinal products containing Acetaminophe-containing products. Mandatory caution regarding chronic, heavy alcohol consumption.

Interaction Classifications

Classification Description
Interaction severity classification Contraindicated (with other Acetaminophen products); Clinically Significant (with chronic Warfarin or heavy alcohol use); Absorption/Exposure Alteration (with Cholestyramine, Probenecid).
Interaction-context constraints Alteration of coagulation only with chronic, daily administration (Warfarin). Hepatotoxicity risk is heightened by chronic, heavy substance exposure (Alcohol).

Official Interaction Statements

Co-administration with other Acetaminophen-containing products is a formal restriction due to the risk of exceeding the dose limit for severe hepatotoxicity. Chronic daily administration can cause a pharmacodynamic increase in the effect of oral anticoagulants (Warfarin), raising the risk of bleeding. Probenecid reduces clearance, leading to an increase in systemic exposure, while Cholestyramine reduces the absorption rate, requiring administration separation. Enzyme Inducers (e.g., Phenobarbital) increase clearance, potentially reducing exposure. Chronic, heavy alcohol consumption is explicitly documented as significantly increasing the risk of severe hepatotoxicity.


Connection to the overall interaction profile: Regulatory documents define the interaction structure of Febrol (Acetolamin) primarily through agents that modify its clearance or absorption (pharmacokinetic interactions) and substances that heighten the risk of specific adverse outcomes (pharmacodynamic interactions). The profile mandates specific co-administration restrictions, including the formal prohibition against taking other Acetaminophen-containing medicines, and requires timing separation for certain absorption-altering substances. This information strictly details the documented patterns of interaction as classified by government regulators.

Mechanism of Action

Febrol, containing paracetamol, exerts its primary pharmacodynamic effects predominantly within the Central Nervous System (CNS). The precise, unified mechanism remains under investigation, but established pathways involve both enzymatic inhibition and receptor modulation.

Paracetamol is considered a weak inhibitor of cyclooxygenase (COX) enzymes, particularly COX-2 and a variant of COX-1 (potentially COX-3), specifically in the CNS tissue where arachidonic acid and peroxide levels are low. This inhibition decreases the synthesis of prostaglandin E2 ( PGE2) in the hypothalamus and spinal cord. PGE2 is a key mediator of elevated systemic temperature and nociceptive signaling.

A secondary, centrally-acting mechanism involves the drug's metabolite, N-acylphenolamine (AM404). This metabolite is formed via FAAH (fatty acid amide hydrolase) and acts as an agonist on Transient Receptor Potential Vanilloid 1 (TRPV1) receptors, and an indirect agonist of Cannabinoid 1 ( CB1) receptors. This cascade potentiates descending serotonergic inhibitory pathways within the spinal cord. The overall system-level physiological consequence is the modulation of thermoregulation in the hypothalamus and attenuation of nociceptive signal transmission through the central nervous system.

Dosage and Administration Information

How Febrol is Used: Administration Guidelines

The principles for using Febrol (Acetolamin) describe standardized administration and adherence to established usage patterns. This medication is formulated as a fast-dissolve oral tablet, intended for the oral route.

Dosing and Frequency

Feature Instruction Summary (Adults and Adolescents 12 years)
Standard Single Dose 325 mg to 1000 mg
Maximum Daily Dose Must not exceed 4000 mg (4 grams) in a 24-hour period
Dosing Interval Minimum of 4 hours must elapse between doses
Intake Condition May be taken with or without food

Usage Constraints and Population-Specific Rules

The medicine is designed for short-term use. Administration is generally limited to a maximum of 10 days for pain relief and 3 days for fever reduction. For populations with specific health factors, such as hepatic impairment, the maximum recommended 24-hour dose may be reduced to 2000 mg (2 grams). Dosing is generally the same for adolescents 12 years and older as for adults. If a dose is not taken on schedule, the next dose should only be taken if the required time interval has passed, as it is not recommended to take a double dose to compensate. These usage instructions describe the protocol for administering the medication.


Recent Clinical Evidence

Research evidence / Overview of studies for Febrol (Acetolamin)

This section provides a patient-friendly overview of the official research landscape for Febrol, describing the types of studies conducted and the specific questions that researchers have explored, without offering interpretations or medical advice.


Research Explored in Mild-to-Moderate Acute Pain

Research focusing on Acetolamin's active ingredient primarily utilized short-term Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time when participants were dealing with acute, temporary discomfort. Researchers specifically monitored patient-reported outcomes related to physical discomfort, such as headache or muscle ache. Studies monitored two main outcomes: changes in pain intensity and the time interval that passed before participants felt the need for additional pain relief.

Findings from these controlled studies describe patterns observed in the measured pain scores within a few hours of the drug being administered. The primary data from these trials were based on single-dose or very short-course usage, typically lasting only up to 48 hours. Data for consistent usage of recurring, non-severe pain over several weeks remains limited in controlled settings, and the results apply mainly to the populations studied.


Research Explored in Elevated Body Temperature (Antipyresis)

Evidence was evaluated in numerous short-term Randomized Controlled Trials (RCTs) exploring use in elevated body temperature, as well as systematic reviews that synthesize these findings. Research examined temporary physiological imbalance, specifically where outcomes related to systemic imbalance were present, such as fever. Trials assessed body temperature changes (measured in degrees) and the time interval for change in temperature to be observed after a dose.

Across various age groups, trials reported how symptoms evolved in the observed populations, documenting the time and extent of changes in temperature measurements within the first few hours after a dose. Certainty remains low for some aspects of use, as existing studies provide limited insight into the temperature response pattern in medically complex or critically ill populations. Research does not determine whether an individual will respond similarly to the group patterns observed.

Frequently Asked Questions (FAQ)

Common questions about Febrol (FAQ)


Q: How long does it usually take for Febrol to start working?

Studies and official information indicate that relief from symptoms is generally observed to begin within approximately 30 minutes following the administration of an oral dose. This onset time reflects how quickly the active ingredient is absorbed into the body.


Q: What is the expected duration of action for a single dose of Febrol?

According to official product information, the symptomatic effects of a single dose are typically described as lasting for approximately four to six hours. This duration represents the time frame during which the medicine is most active in the body before being eliminated.


Q: What should be done if someone accidentally takes too much Febrol?

In the event of an accidental overdose, immediate medical attention is required. Official warnings emphasize that this is necessary even if a person does not feel unwell, due to the critical risk of severe hepatic injury (liver damage) associated with exceeding the maximum dose. It is important to contact a poison control center or emergency services right away.


Q: Does Febrol interact with common pain relievers like ibuprofen?

Official interaction documents primarily issue a strict caution against co-administering Febrol with any other medicine containing Acetolamin. No specific contraindication is routinely documented for co-use with non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen.


Q: Can Febrol affect the results of lab tests?

Yes, official documentation indicates that the active ingredient may interfere with certain laboratory tests. This includes measurements of blood glucose (sugar) and uric acid. It may also affect certain methods used to monitor blood clotting, such as the INR (International Normalized Ratio) test.


Q: Is Febrol the same type of medicine as [Common OTC Drug Name]?

Febrol is classified as an analgesic and antipyretic medicine. Regulatory classifications clarify that it does not belong to the pharmacological class known as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which are a different group of pain and fever relievers.


Q: Does Febrol cause drowsiness or make you tired?

Drowsiness or fatigue are not typically listed among the common or frequent adverse reactions documented in official product labeling. However, official leaflets do contain warnings regarding dizziness as an uncommon side effect.


Q: How often can Febrol be taken (general timing)?

Official administration instructions specify that a minimum interval of four hours must pass between doses. This timing rule is designed to ensure the total dose of the medicine does not exceed the maximum limit in a 24-hour period.


Q: What happens if a dose of Febrol is missed?

Official guidelines on missed doses recommend taking the next scheduled dose only after the required minimum time interval has passed. Official regulatory documents indicate that taking a double dose to compensate is not advised.


Q: Do studies suggest Febrol is effective for its main purpose?

The active ingredient is established in medical literature for its approved purpose of symptomatic relief (pain and fever reduction). Studies are routinely conducted to measure and document changes in pain intensity and elevated body temperature after the medicine is administered.


Q: Are there different strengths or forms of Febrol available?

While the Febrol brand is specifically described as a fast-dissolve oral tablet, the active ingredient (Acetolamin) is widely available from various manufacturers in numerous strengths and dosage forms. These may include caplets, liquids, and other formulations.


Q: Does Febrol interact with birth control pills?

Official regulatory documents and interaction lists do not commonly detail a specific, clinically significant interaction between the active ingredient and oral contraceptive medications (birth control pills).


Q: Is it possible to become dependent on Febrol?

Febrol is not classified as an opioid or a controlled substance by major government regulatory agencies. Official classifications indicate that it does not carry a risk for dependence or abuse.


Q: Can older adults (seniors) use Febrol safely?

Use of the medicine is permitted for older adults with standard dosing. However, caution is advised in this population due to the possibility that age-related changes could affect the function of the liver or kidneys, which process the medicine.


Q: What is the main difference between Febrol and its generic version?

Generic versions contain the identical active ingredient in the same amount and must meet the same quality standards as Febrol. Differences are typically limited to non-active components (excipients), the appearance of the pill, and its retail cost.


Q: Are long-term effects of Febrol well-studied?

Official labeling defines the medicine for short-term use, typically limited to a maximum of 10 days for pain or 3 days for fever. Regulatory warnings consistently emphasize that prolonged use or consistently exceeding the maximum recommended dose increases the risk of severe hepatic injury.


Q: Can Febrol affect my mood or cause anxiety?

Adverse reactions related to mood alteration or anxiety are not commonly or frequently documented in the official safety profiles for this medicine.


Q: Is Febrol a narcotic or a controlled substance?

The medicine is not classified as a narcotic or a controlled substance by government regulatory agencies in major regions.


Q: Why does the packaging say Febrol may cause dizziness?

Official adverse reaction reports that inform patient information leaflets have documented dizziness or vertigo as an uncommon side effect. This means the side effect was observed, but in a small number of people during research.


Q: What does 'bioavailability' mean for a medicine like Febrol?

Bioavailability is a technical term used to describe the proportion of the active ingredient that is absorbed from the digestive system. It indicates how much of the medicine becomes available to the body to produce its intended therapeutic effect.


Q: Is Febrol known to cause sun sensitivity?

Photosensitivity or increased sun sensitivity is not listed as a commonly documented adverse reaction in the official safety profile of the medicine.


Q: Do official patient information leaflets warn about driving while on Febrol?

Official leaflets typically advise caution regarding the ability to drive or operate machinery, as is standard for many medicines. This is often included to cover the uncommon risk of side effects like dizziness.


Q: Is it true that Febrol can cause hair loss?

Alopecia (hair loss) is not documented as a common or frequent adverse reaction in the official safety profile of the medicine.


Q: What is the meaning of the specific safety class Febrol belongs to?

Febrol is classified as an analgesic and antipyretic. Analgesics work to relieve pain, and antipyretics work specifically to reduce an elevated body temperature, or fever.


Q: Can Febrol be safely stopped suddenly, or does it require tapering?

The medicine does not require a gradual reduction (tapering) based on regulatory guidance regarding withdrawal symptoms. It can generally be discontinued without specific instruction on withdrawal.


Q: Is Febrol ever given by injection instead of a pill?

While the Febrol brand itself is an oral tablet, the active ingredient is available in an intravenous (IV) formulation. This injectable form is primarily used in supervised clinical settings to manage pain and fever when a patient is unable to take the medicine by mouth.


Q: Does taking Febrol require specific adjustments to lifestyle or diet?

Regulatory documents explicitly call for caution and highlight the increased risk of severe hepatic injury associated with chronic, heavy consumption of alcohol. This caution is the primary lifestyle factor documented in official regulatory warnings regarding use.


Q: Can Febrol interact with supplements like St. John's wort?

Supplements that act as hepatic enzyme inducers, such as St. John’s wort, may increase the clearance of the active ingredient. This process could potentially reduce the amount of medicine available in the body to have its full effect.


Q: Is it normal to feel a tingling sensation after starting Febrol?

The sensation of tingling (paresthesia) is not listed as a common or frequent adverse reaction in the official safety profile of the medicine.


Q: What happens in the body when Febrol starts to wear off?

The wearing-off period corresponds to the elimination process of the medicine. Once the medicine is absorbed, it is primarily broken down (metabolized) by the liver and then mostly removed from the body through the kidneys in the urine.


Q: Why do official documents refer to Febrol's mechanism as 'unknown'?

Official texts state that the precise, unified way the medicine works is still under investigation. However, established theories describe its actions as involving the weak inhibition of certain enzymes and the modulation of specific receptors located within the central nervous system.


Q: What is the recommended storage temperature for Febrol tablets?

The official storage guidelines require the product to be kept at a Controlled Room Temperature. This is typically defined as a range between 20 C to 25 C (68 F to 77 F).

How should Febrol be stored and disposed of?

Febrol must be stored and disposed of according to strict regulatory instructions to maintain its stability and prevent unauthorized access.

Storage Requirements

The medicine must be stored at Controlled Room Temperature, typically between 20 C to 25 C (68 F to 77 F). Storage must avoid excessive heat (above 40 C) and the product must not be frozen.

To preserve the medication’s integrity, it must be kept in its original container, tightly closed, and protected from moisture and light.

Child-Protection and Disposal

Official labeling mandates that Febrol must be stored out of the sight and reach of children.

For disposal, unused or expired Febrol should not be flushed down the toilet or placed in general household waste (unless mixed with an unappealing substance and sealed in a bag).

Regulatory authorities recommend utilizing a drug take-back program or an authorized collector as the primary method for safe disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Febrol found in:

A-Z Index: